Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2011 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Asset Utilization Ratio of 0.59 for Q1 2026, down 50.72% year-over-year from 1.19 in Q1 2025, and down 24.35% quarter-over-quarter from 0.78 in Q4 2025.
Rigel Pharmaceuticals (RIGL) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.59 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 50.72% year-over-year to 0.59; the TTM figure through Mar 2026 stood at 0.59 (down 50.72% YoY), while the FY2025 annual figure was 0.87, down 31.88% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.59, down from 0.78 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.4 in Q2 2025, with the low at 0.54 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 1.01 (2023), against an average of 0.98.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio soared 87.13% in 2023, then tumbled 50.72% in 2026.
- Rigel Pharmaceuticals' Asset Utilization Ratio stood at 0.96 in 2022, then gained by 4.45% to 1.01 in 2023, then grew by 17.57% to 1.18 in 2024, then sank by 34.14% to 0.78 in 2025, then decreased by 24.35% to 0.59 in 2026.
- Business Quant data shows RIGL's Asset Utilization Ratio at 0.59 in Q1 2026, 0.78 in Q4 2025, and 1.26 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 0.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.54 |
| Mar 31, 2026 | 0.59 |
| Dec 31, 2025 | 0.78 |
| Sep 30, 2025 | 1.26 |
| Jun 30, 2025 | 1.40 |
| Mar 31, 2025 | 1.19 |
| Dec 31, 2024 | 1.18 |
| Sep 30, 2024 | 1.18 |
| Jun 30, 2024 | 1.02 |
| Mar 31, 2024 | 0.99 |
| Dec 31, 2023 | 1.01 |
| Sep 30, 2023 | 1.14 |
| Jun 30, 2023 | 1.05 |
| Mar 31, 2023 | 1.00 |
| Dec 31, 2022 | 0.96 |
| Sep 30, 2022 | 0.73 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.84 |
| Sep 30, 2021 | 0.76 |